IRIS
BREVETTI, GREGORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.842
AS - Asia 1.677
EU - Europa 1.315
SA - Sud America 197
AF - Africa 30
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.778
SG - Singapore 828
RU - Federazione Russa 587
CN - Cina 308
VN - Vietnam 283
BR - Brasile 156
UA - Ucraina 149
DE - Germania 115
IT - Italia 112
HK - Hong Kong 105
FR - Francia 83
FI - Finlandia 72
NL - Olanda 52
GB - Regno Unito 42
SE - Svezia 37
CA - Canada 35
IN - India 25
BD - Bangladesh 22
IE - Irlanda 19
JP - Giappone 19
AR - Argentina 17
MX - Messico 16
PH - Filippine 12
PL - Polonia 11
ES - Italia 10
IQ - Iraq 10
AT - Austria 9
ZA - Sudafrica 9
CI - Costa d'Avorio 7
ID - Indonesia 7
TR - Turchia 7
EC - Ecuador 6
TH - Thailandia 6
AZ - Azerbaigian 5
IR - Iran 5
CZ - Repubblica Ceca 4
PE - Perù 4
PK - Pakistan 4
TW - Taiwan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
HN - Honduras 3
JO - Giordania 3
LT - Lituania 3
LV - Lettonia 3
OM - Oman 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AM - Armenia 2
AU - Australia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
PS - Palestinian Territory 2
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SD - Sudan 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.066
Salva come PNG Salva come JPEG
Città #
Singapore 386
San Jose 210
Chandler 199
Moscow 167
Jacksonville 164
Hong Kong 97
Beijing 95
Ashburn 85
Santa Clara 80
Ho Chi Minh City 74
Hanoi 64
The Dalles 64
Princeton 52
Los Angeles 50
Lauterbourg 47
Amsterdam 46
Boston 46
Millbury 40
Wilmington 34
Munich 31
Dallas 30
Nanjing 30
Buffalo 27
Houston 21
New York 21
Da Nang 15
Boydton 14
Council Bluffs 14
Frankfurt am Main 14
Tokyo 14
Turku 13
São Paulo 12
Boardman 11
Nanchang 11
Ottawa 11
Warsaw 10
Chicago 9
Kronberg 9
Naples 9
Biên Hòa 8
Brooklyn 8
Falls Church 8
Haiphong 8
Hebei 8
Tianjin 8
Toronto 8
Campobasso 7
Chennai 7
Hải Dương 7
Montreal 7
Orem 7
Redondo Beach 7
Atlanta 6
Falkenstein 6
Hefei 6
Helsinki 6
Mexico City 6
Norwalk 6
Nuremberg 6
Rio de Janeiro 6
Baghdad 5
Baku 5
Can Tho 5
Denver 5
Johannesburg 5
Kunming 5
Napoli 5
Seattle 5
Shenyang 5
Bangkok 4
Belo Horizonte 4
Campinas 4
Jiaxing 4
London 4
Orange 4
Phoenix 4
Querétaro 4
Vienna 4
Betim 3
Changsha 3
Charlotte 3
Curitiba 3
Des Moines 3
Dhaka 3
Hangzhou 3
Jakarta 3
Mumbai 3
New Delhi 3
Salt Lake City 3
San Mateo 3
San Miguel de Tucumán 3
Stockholm 3
São Gonçalo 3
Tashkent 3
Tân Tiến 3
Amman 2
Annapolis 2
Asunción 2
Augusta 2
Baltimore 2
Totale 2.614
Salva come PNG Salva come JPEG
Nome #
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 153
Aortic valve sclerosis in patients with peripheral and/or coronary arterial disease. 148
Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication 140
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. 139
Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. 137
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. 136
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 135
Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 127
Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 126
Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification 125
Cellular adhesion molecules and peripheral arterial disease 123
Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index 122
Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis 117
Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners. 113
Intermittent claudication in Italy. The Peripheral Arteriopathy and Cardiovascular Events (PACE) study 113
Early vascular alterations in acromegaly 113
Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. 110
Prevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number 110
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease 109
Statin therapy in patients with subclinical and evident peripheral artery disease: a meta-analysis 109
Peripheral arterial disease: the magnitude of the problem and its socioeconomic impact. 106
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb. 105
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. 102
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 102
Effects of AT1 receptor antagonism with candesartan on endothelial function in patients with hypertension and coronary artery disease. 101
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb 99
Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose-titration, multicenter study 94
Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease 91
Carnitine-related alterations in patients with intermittent claudication. Indication for a focused carnitine therapy 90
EARLY VASCULAR ALTERATIONS IN ACROMEGALY 88
Intermittent claudication: an historical perspective 87
The prevalence of hypoechoic carotid plaques is greater in peripheral than in coronary artery disease and is related to the neutrophil count 87
EUROPEAN MULTICENTER STUDY ON PROPIONYL-L-CARNITINE IN INTERMITTENT CLAUDICATION 85
Women and peripheral arterial disease: same disease, different issues 85
Intermittent claudication and endothelial dysfunction 82
Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function 82
Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? 80
MUSCLE CARNITINE DEFICIENCY IN PATIENTS WITH SEVERE PERIPHERAL VASCULAR DISEASE 79
Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication 79
Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermitent claudication 79
Intermittent Claudication. Pharmacoeconomic and Quality of life aspects of treatment 77
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not with classic risk factors and atheroscloritic burden 74
Microcirculation and tissue metabolism in peripheral arterial disase 74
High Levels of adhesion molecules are associated with impaired endothelium-mediated vasodilation in patients with peripheral arterial disease 68
Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease. 66
Metabolic syndrome and cardiovascolar risk prediction in peripheral arterial disease. 65
Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease 65
Effective treatment of orthostatic hypotension by propranolol in the Shy-Drager syndrome. 65
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 64
Infrarenal abdominal aortic aneurysms 61
In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 60
Relationship between insulin-like growth factor-1 system and exercise tolerance in patients with intermittent claudication. 52
Totale 5.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022251 3 0 0 2 2 6 8 8 25 9 72 116
2022/2023452 58 57 8 45 37 44 52 29 61 46 12 3
2023/2024192 6 48 29 11 8 10 0 17 4 8 32 19
2024/20251.245 73 69 1 8 84 20 114 92 101 106 477 100
2025/20262.280 258 109 273 233 453 117 258 87 258 135 61 38
2026/202719 19 0 0 0 0 0 0 0 0 0 0 0
Totale 5.099